Læknablaðið - 15.02.2009, Page 32

,jí<ir
Heimildir:
1. Gonzales D et al. Varenicline, an á4á2 nicotinic acethylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking
cessation. A randomized controlled trial. JAMA 2006; 296(1 ):47-55
2. Jorenby DE et al. Efficacy of varenicline, an á4á2 nicotinic acethylcholine receptor partial agonist, vs sustained-release bupropion and placebo for
smoking cessation. A randomized controlled trial. JAMA 2006; 296(1):56-63
3. Tonstad S et al. Effect of maintenance therapy with varenicline on smoking cessation. A randomized controlled trial. JAMA 2006; 296(1 ):64-71
4. Aubin H et al. Varenicline versus transdermal nicotine patch for smoking cessation: Results from a randomised, open-label trial. Thorax online,
February 8th 2008. Downloaded from thorax.bmj.com on 19. February 2008.
*Byggt á MNWS (Minnesota Nicotine Withdrawal Scale), stuttur spurningalisti um löngun í að reykja og aðlagaður spurningalisti um reykingar.